Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Member of the Compensation Committee
Since 2018, elected until 2023
1957, US-American citizen
Education | Ph.D in Biochemistry and Cell Biology, The Rockefeller University, New York, USA; Bachelor in Biochemical Sciences, Harvard University, Cambridge, USA |
Professional background | |
2014 to present | Consultancy for various companies in the Life Sciences, Bio-Pharmaceutical, and Diagnostics industry. Consultant to RADx program of US Government DHHS/NIH/NIBIB for COVID-19 diagnostics |
2006 – 2014 | PerkinElmer, Inc., USA (NYSE: PKI) In his last role as Senior Vice President and Chief Scientific Officer, he was responsible for all science and technology as well as research and development activities and also led several acquisitions during that time. Additional positions at PerkinElmer: President, Emerging Diagnostics, Waltham, USA and Shanghai, China President, Greater China, Shanghai, China |
2000 – 2006 | Cambrex Corporation, USA (NYSE: CBM) Vice President and Chief Technology Officer, Biotechnology Vice President Research and Development, Biosciences |
1994 – 2000 | Sr. Vice President and Chief Scientific Officer, Osiris Therapeutics, Inc |
1986 – 1995 | Cold Spring Harbor Laboratory, USA Sr. Staff Investigator |
1984 – 1986 | Staff Fellow, National Institutes of Health, USA |
Other activities | |
RareCyte, Inc. 2, Member of the Board of Directors; InVivo Therapeutics Corp1, Member of the Board of Directors; Elevian Inc. 2, Member of the Board of Directors. |
1 public company
2 private company